Incivek

Incivek (telaprevir) Patient Guide: How to Get Incivek at Low or No Cost

Important Notice: Incivek (telaprevir) has been discontinued by the manufacturer, Vertex Pharmaceuticals. There is no current patient assistance program (PAP) available for this medication as of 2026. This guide provides historical information about the former program for reference, but patients should consult healthcare providers for modern hepatitis C treatments and assistance options.[1][5]

About Incivek (telaprevir)

Incivek, known generically as telaprevir, was an oral medication approved by the FDA in May 2011 as a direct-acting antiviral (DAA) for treating genotype 1 chronic hepatitis C virus (HCV) in adults with compensated liver disease, including cirrhosis.[4] It targeted the HCV NS3/4A protease enzyme essential for viral replication.[6]

Incivek was never used alone. It required combination with peginterferon alfa and ribavirin for 12 weeks, followed by additional weeks of the other two drugs based on viral response and treatment history (total 24-48 weeks).[3][4] Dosage was 750 mg three times daily (7-9 hours apart) with food.[4]

Clinical trials showed strong results: 79% of treatment-naïve patients achieved sustained viral response (SVR, or cure) vs. 46% with interferon/ribavirin alone. Prior relapsers saw 86% SVR vs. 22%; partial responders 59% vs. 15%; null responders 32% vs. 5%.[6] Common side effects included rash, anemia, fatigue, itching, nausea, and anal discomfort. Serious risks: severe rash (including Stevens-Johnson syndrome), anemia requiring transfusions, and drug interactions.[3][4]

Why was it discontinued? Newer, safer, shorter oral DAAs (e.g., sofosbuvir-based regimens) replaced older interferon combinations like Incivek starting around 2013-2014 due to better efficacy, fewer side effects, and no interferon.[1] Incivek is no longer manufactured or available via prescription.[1][5]

Who Qualifies for Assistance?

When active (2011-~2014), Vertex offered Vertex GPS (Guidance & Patient Support) for Incivek, including multiple aid types:[1][5]

• Vertex Free Medicine Program: Free Incivek for uninsured patients (not on other benefits) with household income ≤ $100,000/year.[1]
• Co-Pay Support: Covered up to 20% of Incivek costs for privately insured patients.[2]
• Case Management: Free help researching insurance, appeals, and other aid via Vertex case managers.[1]
• Donations to PAN Foundation: Co-pay help for underinsured HCV patients.[1]

No formal FPL (Federal Poverty Level) thresholds were specified beyond the $100K cap for free drug; eligibility focused on lack of insurance/coverage.[1] Medicare patients might access via PAN or other routes, but program targeted uninsured/underinsured primarily.[1][5]

Income Eligibility Breakdown

*Historical; flat $100K household cap, not scaled by FPL or size.[1] Co-pay aid had separate private insurance criteria.[2] Today: No active program.

Insurance Requirements

• Free Medicine: Required no insurance or other coverage for Incivek.[1]
• Co-Pay Support: Needed private insurance covering Incivek (Vertex paid up to 20% coinsurance).[2]
• Medicare/Government Insurance: Not directly eligible for free drug; case managers helped with appeals or alternatives like PAN Foundation.[1][5]

Vertex GPS assisted all patients with insurance navigation, regardless of type.[1][5]

Step-by-Step Application Process (Historical)

1. Contact Vertex GPS: Call 1-855-837-8394 or visit www.incivek.com/vertex-guidance-patient-support (now defunct).[5]
2. Consult Your Doctor: Get Incivek prescription + proof of HCV diagnosis (genotype 1).
3. Case Manager Assignment: Free specialist reviews insurance, income, and eligibility.
4. Submit Documents: Income proof (tax returns), insurance details (or proof of none), prescription, doctor's statement.[1]
5. Approval/Processing: If eligible, medication shipped free or co-pay voucher issued.

Today: No applications accepted. Use resources like NeedyMeds, RxAssist, or PAN for current HCV drugs.[5]

Timeline and Delivery

• Processing: Not specified; case managers expedited (days to weeks).[1]
• Delivery: Free shipping to home/doctor via specialty pharmacy.[1]
• Supply Duration: 12-week course initially; reauthorized as needed.[4]

If Denied or No Longer Eligible

• Appeal: Case managers helped with insurance appeals.[1]
• Alternatives:
  • PAN Foundation (co-pay aid for HCV).[1][5]
  • NeedyMeds/RxAssist databases for other programs.[5]
  • Current HCV Treatments: Modern DAAs via Gilead, AbbVie PAPs (e.g., Harvoni, Mavyret) – often 400% FPL, low/no cost.[5]
  • ADAP/State Programs: For uninsured/underinsured.[5]

No biosimilars for telaprevir (discontinued DAA).[ ]

Reauthorization and Refills

12-week Incivek course; doctor requested extensions via GPS. Case managers handled refills.[1][4]

Disclaimer

This guide is for educational purposes only and reflects a discontinued program.[1][5] Incivek/telaprevir is no longer available.[1] Do not seek this drug; it poses risks without modern standards. Consult your doctor for current genotype 1 HCV options (e.g., glecaprevir/pibrentasvir, sofosbuvir/velpatasvir) with active PAPs. Assistance info may change; verify via official sources. Not medical/financial advice. Word count: 942.